1. Home
  2. MYMD
  3. MYMD News

Latest MyMD Pharmaceuticals Inc. (MYMD) News on July 5, 2024

MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer
MYMD

Business Wire

18 days ago

MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer

MyMD Pharmaceuticals Secures Strategic Investments
MYMD

Business Wire

a month ago

MyMD Pharmaceuticals Secures Strategic Investments

MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
MYMD

Business Wire

4 months ago

MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing

MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
MYMD

Business Wire

5 months ago

MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing

Here's Why We're Not Too Worried About MediWound's (NASDAQ:MDWD) Cash Burn Situation
MYMD

Simply Wall St.

5 months ago

Here's Why We're Not Too Worried About MediWound's (NASDAQ:MDWD) Cash Burn Situation

Envirotech Vehicles Announces EPA Clean School Bus Grant Program Award of $8.57 Million for 25 of its Fully Electric School Buses
MYMD

ACCESSWIRE

5 months ago

Envirotech Vehicles Announces EPA Clean School Bus Grant Program Award of $8.57 Million for 25 of its Fully Electric School Buses

Grove Collaborative Surpasses 15 Million Pounds of Nature-Bound Single-Use Plastic Collected Through Plastic Neutrality Commitment & Partnerships
MYMD

Business Wire

6 months ago

Grove Collaborative Surpasses 15 Million Pounds of Nature-Bound Single-Use Plastic Collected Through Plastic Neutrality Commitment & Partnerships

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024
MYMD

GlobeNewswire

6 months ago

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

Comstock Acquires and Retires Over 2.6 Million Common Shares
MYMD

GlobeNewswire

6 months ago

Comstock Acquires and Retires Over 2.6 Million Common Shares

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?
MYMD

Zacks

6 months ago

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?

42West Rebrands BHI to Fandoms & Franchises
MYMD

ACCESSWIRE

6 months ago

42West Rebrands BHI to Fandoms & Franchises

Smith-Midland Appoints New Members to its Board of Directors
MYMD

ACCESSWIRE

6 months ago

Smith-Midland Appoints New Members to its Board of Directors

MYMD

Business Wire

6 months ago

ElectraMeccanica Vehicles Corp. Reports Results of 2023 Annual General Meeting of Shareholders

Zacks Industry Outlook Highlights EMCOR, Granite Construction and Orion Group
MYMD

Zacks

7 months ago

Zacks Industry Outlook Highlights EMCOR, Granite Construction and Orion Group

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference
MYMD

PR Newswire

7 months ago

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference

MYMD

Business Wire

7 months ago

ElectraMeccanica Provides Shareholders with December CEO Update

MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis
MYMD

Business Wire

7 months ago

MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis

CORRECTION – Xcel Brands, Inc. and Fashion Icon Christie Brinkley form Joint Venture
MYMD

GlobeNewswire

7 months ago

CORRECTION – Xcel Brands, Inc. and Fashion Icon Christie Brinkley form Joint Venture

Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS® In Vivo Gene Editing as a Potentially Curative Treatment for Mitochondrial Diseases
MYMD

Business Wire

7 months ago

Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS® In Vivo Gene Editing as a Potentially Curative Treatment for Mitochondrial Diseases

Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management
MYMD

Newsfile

7 months ago

Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management

Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform
MYMD

GlobeNewswire

7 months ago

Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera’s Next Generation Oral Peptide Platform

MYMD

Business Wire

7 months ago

ElectraMeccanica and Tevva Resolve Merger Litigation

Veritone Joins the Generative AI Center of Excellence for AWS Partners
MYMD

Business Wire

7 months ago

Veritone Joins the Generative AI Center of Excellence for AWS Partners

MYMD

Zacks Small Cap Research

8 months ago

CRVO: Publications Highlight Neflamapimod as Potential Disease-Modifying Therapy for Major Dementias…

CervoMed Reports Third Quarter 2023 Financial Results and Business Highlights
MYMD

PR Newswire

8 months ago

CervoMed Reports Third Quarter 2023 Financial Results and Business Highlights

MYMD

Business Wire

8 months ago

Update on ElectraMeccanica Litigation Dispute With Tevva

MYMD

Associated Press Finance

8 months ago

Psychemedics: Q3 Earnings Snapshot

Psychemedics Corporation Reports Third Quarter 2023 Financial Results
MYMD

GlobeNewswire

8 months ago

Psychemedics Corporation Reports Third Quarter 2023 Financial Results

Share on Social Networks: